The DOI matches its Crossref record.
Incremental Direct Expenditure of Treating Asthma in the United States
Abstract
OBJECTIVE: There is a wide range in the estimates of cost of asthma that are available in the literature. Given the growing prevalence of asthma and its associated healthcare resource use in the United States (U.S.), it is important to obtain current and precise cost estimates attributable to asthma treatment. The objectives of this study were to estimate the incremental direct expenditures associated with asthma in the U.S. METHODS: Retrospective analysis was conducted using the 2004 Medical Expenditure Panel Survey (MEPS) data that are representative of the civilian non-institutionalized population of the U.S. Asthma respondents were identified as those with International Classification of Diseases-9-Clinical Modification (ICD-9-CM) diagnosis codes for asthma in 2004 or those who had a self-report of having asthma in 2004. Incremental total expenditures and expenditures for various categories of resource use including physician office visits, emergency room visits, outpatient visits, inpatient visits, medications, and other medical visits associated with asthma were estimated separately in children (age < 18 years) and in adults (age > or = 18 years) using generalized linear regression models. The models were adjusted for covariates including age, gender, race, ethnicity, education, marital status (for age group > or = 18 years), geographic region, insurance status, and comorbidities. RESULTS: The prevalence of asthma among children and adults in 2004 was estimated at 8.7% (6.4 million persons) and 6.72% (14.8 million persons), respectively. The annual adjusted mean incremental total expenditure associated with asthma was $1,004.6 (SE: $326.1; p = 0.002) per person among children and was $2,077.5 (SE: $544.5; p < 0.0001) per person among adults, after adjusting for covariates. Prescription medications and physician office visits were the major drivers of total expenditures and constituted approximately 38% and 49% of the total incremental expenditures for asthma in children and adults, respectively. Inpatient visit expenditures were high in both age groups but were not significantly different from zero. CONCLUSION: Given the prevalence of asthma among U.S. children and adults and its associated incremental expenditures, the annual direct medical expenditure attributable to asthma treatment is estimated at approximately $37.2 billion in 2007 U.S. dollars representing a significant portion of healthcare resource use in the U.S.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The Economic Burden of Asthma in the United States, 2008–2013
Nurmagambetov, T., Kuwahara, R., & Garbe, P. (2018) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201703-259oc · Cited by 842
Costs of asthma in the United States: 2002-2007
Barnett, S. B. L., & Nurmagambetov, T. A. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.020 · Cited by 607
Incremental Health Care Utilization and Expenditures for Chronic Rhinosinusitis in the United States
Bhattacharyya, N. (2011) · Annals of Otology, Rhinology & Laryngology · doi:10.1177/000348941112000701 · Cited by 341
Choung, R. S., Shah, N. D., Chitkara, D., Branda, M. E., Van Tilburg, M. A., Whitehead, W. E., Katusic, S. K., Locke, G. R., & Talley, N. J. (2011) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181e67058 · Cited by 103
Bhattacharyya, N. (2011) · The Laryngoscope · doi:10.1002/lary.22034 · Cited by 74
Metadata
- Authors
- Kamble, S., & Bharmal, M.
- Venue
- Journal of Asthma
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 46
- Issue
- 1
- Pages
- 73-80
- ISSN
- 0277-0903 (ISSN-L)
- 1532-4303
- OpenAlex
- W2078361216
- Cited by
- 178
- References
- 0
- FWCI
- 14.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Incremental Direct Expenditure of Treating Asthma in the United States. https://app.cochat.ai/papers/10.1080/02770900802503107
- The paper
- Kamble, S., & Bharmal, M. (2009). Incremental Direct Expenditure of Treating Asthma in the United States. Journal of Asthma. https://doi.org/10.1080/02770900802503107
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.